A Phase I/II Trial of CHOEP Chemotherapy Plus Lenalidomide as Front Line Therapy for Patients With Stage II, III and IV Peripheral T-Cell Non-Hodgkin's Lymphoma
Phase of Trial: Phase I/II
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Lenalidomide (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Prednisone; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions; Therapeutic Use
- 07 Jul 2017 Planned primary completion date changed from 1 Mar 2020 to 1 Oct 2020.
- 30 Oct 2016 Status changed from not yet recruiting to recruiting.
- 02 Oct 2015 Planned initiation date changed from 1 Mar 2015 to 1 Nov 2015 as reported by ClinicalTrials.gov record.